A new innovation fund has been launched in Canada to support the country’s biotech sector.
Life sciences giant, Merck, has joined with Canada’s Centre for Drug Research and Development (CDRD), to provide $1.5 million in support to advance therapies being developed at the centre.
“This collaborative partnership further illustrates that Merck is committed to contributing to Canada’s flourishing life sciences sector, which represents an enormous opportunity for economic growth and health innovation. We are committed to working collaboratively with governments, universities and other stakeholders to discover, develop and implement health solutions that improve patient outcomes in a manner that is consistent with the sustainability of our healthcare system,” said Jennifer Chan, Vice President, Policy and External Affairs, Merck Canada.
There have a number of stories on these pages about Canada’s .Writing for Innovators Magazine earlier this year, Andrew Casey, President and CEO, BIOTECanada, said the country boasts a buoyant sector.
While Canada’s Minister of Innovation, Science and Economic Development, Navdeep Bains, wrote recently on Linkedin that Canada “has led the way in the global biotech industry for so many years with advances in areas like genomics, stem cell and regenerative medicine, and metabolic disorders such as diabetes, with the discovery of insulin.